Synendos Therapeutics

Synendos Therapeutics closes venture funding round


Synendos Therapeutics have received a CHF 20m investment from Lichtsteiner Foundation, Zürcher Kantonal Bank, High-Tech Grunderfonds, Kurma Partners, Essential Investment Partners, Bernina BioInvest, Schroder Adveq, Sunstone Life Science Ventures to support their product development and scaling. Hiring is expected as the company undergoes a period of significant growth.

Spotlight

86

Related Events